172 related articles for article (PubMed ID: 31324464)
1. Upper gastrointestinal bleeding due to overdose of selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory drugs.
Sanz Segura P; García Cámara P; Gotor Delso J; Monzón Báez RM; Llorente Barrio M; Fernández Bonilla E; Bernal Monterde V
Gastroenterol Hepatol; 2019 Dec; 42(10):622-623. PubMed ID: 31324464
[No Abstract] [Full Text] [Related]
2. Risk of ulcer soars with combination of arthritis drugs.
Gottlieb S
West J Med; 2001 Apr; 174(4):236. PubMed ID: 11290669
[No Abstract] [Full Text] [Related]
3. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
de Abajo FJ; García-Rodríguez LA
Arch Gen Psychiatry; 2008 Jul; 65(7):795-803. PubMed ID: 18606952
[TBL] [Abstract][Full Text] [Related]
4. [Desvenlafaxine and neuropathic pain: additional clinical benefits of a second generation serotonin-noradrenaline reuptake inhibitor].
Alcantara-Montero A
Rev Neurol; 2017 Mar; 64(5):219-226. PubMed ID: 28229443
[TBL] [Abstract][Full Text] [Related]
5. Cameron lesions and selective serotonin reuptake inhibitors: An uncommon combination.
Izquierdo Romero M; Rodríguez Prida J; Hermida Pérez B; Salman Monte Z
Gastroenterol Hepatol; 2020 May; 43(5):264-265. PubMed ID: 32063438
[No Abstract] [Full Text] [Related]
6. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?
Tata LJ; Fortun PJ; Hubbard RB; Smeeth L; Hawkey CJ; Smith CJ; Whitaker HJ; Farrington CP; Card TR; West J
Aliment Pharmacol Ther; 2005 Aug; 22(3):175-81. PubMed ID: 16091054
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
[TBL] [Abstract][Full Text] [Related]
9. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.
de Abajo FJ; Rodríguez LA; Montero D
BMJ; 1999 Oct; 319(7217):1106-9. PubMed ID: 10531103
[TBL] [Abstract][Full Text] [Related]
10. [Is the use of selective serotonin reuptake inhibitors associated with an increased risk of bleeding?].
Dall M; Hallas J
Ugeskr Laeger; 2006 Jun; 168(23):2232-6. PubMed ID: 16768974
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal bleeding and possible hypothyroidism.
Marshall LL
Consult Pharm; 2012 Mar; 27(3):180-8. PubMed ID: 22421518
[TBL] [Abstract][Full Text] [Related]
12. Alendronate and naproxen are synergistic for development of gastric ulcers.
Graham DY; Malaty HM
Arch Intern Med; 2001 Jan; 161(1):107-10. PubMed ID: 11146706
[TBL] [Abstract][Full Text] [Related]
13. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.
Cheatum DE; Arvanitakis C; Gumpel M; Stead H; Geis GS
Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs and peptic ulcers.
Hawkey CJ
BMJ; 1990 Feb; 300(6720):278-84. PubMed ID: 2106956
[No Abstract] [Full Text] [Related]
15. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.
Renoux C; Lix LM; Patenaude V; Bresee LC; Paterson JM; Lafrance JP; Tamim H; Mahmud SM; Alsabbagh MW; Hemmelgarn B; Dormuth CR; Ernst P;
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1716-22. PubMed ID: 26231193
[TBL] [Abstract][Full Text] [Related]
16. Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome.
Theoharides TC; Asadi S; Weng Z; Zhang B
J Clin Psychopharmacol; 2011 Aug; 31(4):403-5. PubMed ID: 21694612
[No Abstract] [Full Text] [Related]
17. Dangerous side effects of NSAIDs.
Rasanathan M
N Z Med J; 1994 Sep; 107(985):361. PubMed ID: 8078627
[No Abstract] [Full Text] [Related]
18. Risk of acute upper gastrointestinal bleeding in patients with ulcerative disease and treatment with non-steroidal anti-inflammatory drugs (NSAIDs). Results from the Comprehensive Hospital Drug Monitoring Berne (CHDM).
Stodolnik E; Maurer P; Hoigné R; Hess T; Müller U; Amonn F; Halter F; Maibach R; Künzi UP
Eur J Clin Pharmacol; 1990; 38(1):31-5. PubMed ID: 2328744
[TBL] [Abstract][Full Text] [Related]
19. Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature.
Mort JR; Aparasu RR; Baer RK
Pharmacotherapy; 2006 Sep; 26(9):1307-13. PubMed ID: 16945053
[TBL] [Abstract][Full Text] [Related]
20. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.
Anglin R; Yuan Y; Moayyedi P; Tse F; Armstrong D; Leontiadis GI
Am J Gastroenterol; 2014 Jun; 109(6):811-9. PubMed ID: 24777151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
